Trillium Therapeutics
$4.119876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-1.20%) As of 1:58 PM EST today
-$0.05 (-1.20%) Today
Why Robinhood?
You can buy or sell TRIL and other stocks, options, ETFs, and crypto commission-free!
About TRIL
Trillium Therapeutics Inc. Common Shares, also called Trillium Therapeutics, is a clinical stage immuno-oncology company, which engages in the development of therapies for the treatment of cancer. Read More Its pipeline is comprised of TTI-621, TTI-622, and TTI-2341(EGFR Inhibitor). The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.
CEO
Employees
60
Headquarters
Mississauga, Ontario
Founded
2004
Market Cap
261.27M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.62M
High Today
$4.45
Low Today
$3.92
Open Price
$4.18
Volume
2.66M
52 Week High
$4.86
52 Week Low
$0.2405
Collections
TRIL Earnings
-$0.91
-$0.61
-$0.30
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 11, Pre-Market
People Also Bought
Oragenics
47,581
$0.5782
+2.61%FuelCell Energy
53,564
$2.51
-3.83%Actinium Pharmaceuticals
10,121
$0.2646
+5.33%Titan Pharmaceuticals
19,355
$0.2368
-2.67%Advaxis
11,064
$0.9686
-5.04%Ocugen, Inc
10,881
$0.5254
-2.70%Ameri Holdings
716
$1.30
+0.05%Cyclacel Pharmaceuticals
1,459
$0.717
+4.82%Viking Therapeutics
38,948
$6.89
-1.01%NIO
127,886
$4.07
-4.38%Biocept
20,077
$0.3323
+0.09%Onconova Therapeutics
20,532